NCT07065032 - A Study of ZT002 Injection in Adult Chinese Subjects With Type 2 Diabetes Mellitus (T2DM) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 19, 2024

Primary Completion Date

July 22, 2024

Study Completion Date

August 5, 2024

Conditions

Type 2 Diabetes

Interventions

DRUG

ZT002 Injection

Q2W, subcutaneous injection

DRUG

ZT002 Injection

Q2W, subcutaneous injection

DRUG

ZT002 Placebo

Participants will receive the same volume as the study drug in each cohort.

Trial Locations (1)

The Affiliated Hospital of Qingdao University Phase I Clinical Research Center, Qingdao